Telesis Bio Inc Enterprise value
What is the Enterprise value of Telesis Bio Inc?
The Enterprise value of Telesis Bio Inc is $31.77M
What is the definition of Enterprise value?
Enterprise value is a measure of a company’s total market value. It is calculated as market capitalization with debt, minority interest, and preferred shares minus total cash and cash equivalents.
ttm (trailing twelve months)
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Enterprise value of companies in the Health Care sector on NASDAQ compared to Telesis Bio Inc
What does Telesis Bio Inc do?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Companies with enterprise value similar to Telesis Bio Inc
- Agenus Inc has Enterprise value of $31.66M
- EFH has Enterprise value of $31.67M
- Trio Industrial Electronics has Enterprise value of $31.69M
- Strategic Minerals NL has Enterprise value of $31.75M
- SciDev has Enterprise value of $31.75M
- Zenith Birla (India) has Enterprise value of $31.75M
- Telesis Bio Inc has Enterprise value of $31.77M
- Prairie Mining has Enterprise value of $31.80M
- Cocoon has Enterprise value of $31.81M
- Altus has Enterprise value of $31.82M
- Irving Resources has Enterprise value of $31.83M
- KEFI Minerals Plc has Enterprise value of $31.88M
- Anxian Yuan China has Enterprise value of $31.92M